The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.
Clinical trial NCT05010200 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05010200
- Sponsor
- Ashutosh Kumar Tewari
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2027-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.